Skip to main content

Peer Review reports

From: Robustness of the healthcare utilization results from the Rotavirus Efficacy and Safety Trial (REST) evaluating the human-bovine (WC3) reassortant pentavalent rotavirus vaccine (RV5)

Original Submission
9 Nov 2009 Submitted Original manuscript
13 Jan 2010 Reviewed Reviewer Report - Mark Jit
7 Apr 2010 Reviewed Reviewer Report - Shally Awasthi
7 May 2010 Author responded Author comments - Robbin Itzler
Resubmission - Version 2
7 May 2010 Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
11 May 2010 Author responded Author comments - Robbin Itzler
Resubmission - Version 4
11 May 2010 Submitted Manuscript version 4
13 May 2010 Reviewed Reviewer Report - Mark Jit
Resubmission - Version 5
Submitted Manuscript version 5
Resubmission - Version 6
Submitted Manuscript version 6
Resubmission - Version 7
Submitted Manuscript version 7
Resubmission - Version 8
Submitted Manuscript version 8
7 Jun 2010 Author responded Author comments - Robbin Itzler
Resubmission - Version 9
7 Jun 2010 Submitted Manuscript version 9
Publishing
11 Jun 2010 Editorially accepted
11 Jun 2010 Article published 10.1186/1471-2431-10-42

You can find further information about peer review here.

Back to article page